QR Code

Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Full description

Saved in:
Main Authors: Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Surgery
Subjects:
low-grade glioma (WHO grade II)
cost
resection
stereotactic biopsy
adverse events—complications
MarketScan database
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items